n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, July 26th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Prism Technologies Group, Inc. (PRZM)

Zacks, MarketWatch, Nasdaq, Wall Street Journal, TradingView, Bloomberg, and InvestorsHub reported on Prism Technologies Group, Inc. (PRZM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Prism Technologies Group, Inc. is an intellectual property (IP) licensing and technology research & development (R&D) enterprise. The Company, by way of its wholly-owned subsidiaries, owns a patent portfolio comprising nine patent families incorporating 61 issued and six pending patents in the Computer & Network Security, Semiconductors, and Medical Technology space.

Established in 1995, Prism Technologies Group has its corporate office in Folsom, California. Prism Technologies Group is the parent company of Prism Technologies, LLC, which is a Nebraska Limited Liability Company (LLC) based in Omaha, Nebraska.

Prism Technologies Group was previously known as Internet Patents Corporation. It changed its name to Prism Technologies Group, Inc. in September of 2015. The Company licenses and enforces a portfolio of patents relating to its technologies. It continues to develop and patent new technologies.

The Company’s dedication is to continuing R&D efforts in a number of fields. Its corporate mission is to continue to develop and invent new technologies in computer and network security, wearable computing, transaction processing, as well as healthcare to hasten time to market opportunities for its clients.

This past May, Prism Technologies Group announced that the Court of Appeals for the Federal Circuit rejected a request by Sprint Spectrum LP d/b/a Sprint PCS for a rehearing of Sprint’s appeal of the patent infringement verdict, in favor of Prism Technologies Group subsidiary, Prism Technologies LLC.

In June of 2015, a jury in the United States District Court for the District of Nebraska found that the accused Sprint network systems and methods infringe numerous claims of U.S. Patent Nos. 8,387,155 and 8,127,345, and Prism LLC was awarded trial damages of $30 million. In addition, Prism LLC was awarded $2 million in prejudgment interest and will be entitled to post-judgment interest in an amount to be determined.

The Federal Circuit issued its mandate on May 15, 2017, transferring jurisdiction of the case back to the District Court. Sprint, however, has until August 7, 2017 to appeal the case to the U.S. Supreme Court, which is not obligated to accept the appeal. This suit against Sprint (8:12-cv-123-LES-TDT) is the second of five patent infringement lawsuits filed by Prism LLC against wireless carriers in U.S. District Court for the District of Nebraska.

nFüsz, Inc. (PRZM), closed Wednesday's trading session at $0.2831, down 2.35%, on 45,467 volume with 24 trades. The average volume for the last 60 days is 15,567 and the stock's 52-week low/high is $0.1401/$1.06.

Sustainable Petroleum Group, Inc. (SPGX)

OTC Markets, MarketWatch, Bloomberg, Market Exclusive, and OilandGas360 reported on Sustainable Petroleum Group, Inc. (SPGX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sustainable Petroleum Group, Inc. is a member of SP Group. Sustainable Petroleum is positioned to become a world leading natural resources holding and development enterprise via value based investments and collaborative partnerships with international leaders across the natural resources sector. The Company is headquartered in Naples, Florida.

SP Group has started its objectives through pursuing investment and partnerships with some of the most diversified and integrated companies available on the market. Its dedication is to negotiating working interests (WIs) in a wide spectrum of natural resource projects globally. SP Group uses the local knowledge and expertise of companies that operate its interests. Therefore, it benefits as non-operators from low-risk opportunities to provide a steady stream of resources to the worldwide market.

SP Group’s goal is to invest into undervalued global companies via direct investment. In addition, it is negotiating investment and collaboration agreements with different worldwide leaders across the natural resource industry.

Regarding its portfolio, SP Group selects its investments and partnerships only from well established companies with a proven record of accomplishment and that bring strong project experience to the Company.

Earlier this month, Sustainable Petroleum Group announced a new global representative office. Effective July 8, 2017, the Company has a representative office in Zurich, Switzerland.

Its acquisition of 20 percent of shares of SP Group (Europe) AG presented an opportunity to increase its international footprint. The four-story building will give Sustainable Petroleum Group the ability to house greater than 100 employees. This will provide the Company room to grow as it expands its European investment activities.

Through this acquisition of SP Group (Europe) AG shares, Sustainable Petroleum Group is gaining direct access to its sister company, SPG. Presently, SP Group (Europe) AG maintains a project portfolio of approximately 20 projects.

Christian Winzenried, Sustainable Petroleum Group’s Chief Executive Officer, stated, "Through our new investment in SPG, we are pleased to be participating with a company focused on becoming a worldwide leader in the field of natural resources."

Sustainable Petroleum Group, Inc. (SPGX), closed Wednesday's trading session at $4.00, down 20.00%, on 1,900 volume with 3 trades. The average volume for the last 60 days is 2,863 and the stock's 52-week low/high is $1.10/$6.00.

AlphaPoint Technology, Inc. (APPO)

Market Watch, Market Exclusive, Bloomberg, TradingView, and Wall Street Journal reported on AlphaPoint Technology, Inc. (APPO), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

AlphaPoint Technology, Inc.’s corporate vision is to partner with innovative technology focused companies interested in pursuing growth via the public markets. Established in 2009, the Company is assembling a portfolio of high-quality businesses and establishing a sustainable business model. AlphaPoint Technology is headquartered in Sarasota, Florida. The Company lists on the OTC Markets Group’s OTCQB.

AlphaPoint Technology centers on businesses that strategically fit within its existing business portfolio, or expands its portfolio into new and attractive target markets. The Company’s intention is to accomplish its goals by way of targeted strategic acquisitions and partnerships.

AlphaPoint Technology began as a provider and developer of a Patent Pending, Data Center Management Software - AssetCentral™. This is a pioneering, user-friendly, Web-based IT Asset Management (ITAM software) and Data Center Infrastructure Management (DCIM software) solution.

The Company continued its growth and development of AssetCentral™. It was able to build a strong customer base, which included recognizable brands and organizations. AlphaPoint no longer markets AssetCentral™. Nonetheless, it still maintains full ownership of the intellectual property (IP). Presently, it is seeking licensing and ownership opportunities.

Typically, AlphaPoint Technology’s business units will operate as stand-alone operations. However, they are supported by an experienced executive team and a shared technology and administrative infrastructure.

The Company uses proven leadership experience that includes everything from cash flow optimization techniques, and realignment of cost structures, to development of capital and liquidity strategies, and transitioning from a private to a public entity.

Earlier this month, AlphaPoint Technology announced it entered into a Letter of Intent (LOI) to acquire Home Bistro, Inc. The LOI is non-binding; it may be terminated by either party at any time. The transaction is subject to completion of due diligence review and customary closing conditions. The anticipation is that the transaction will close on or about September 15, 2017.

Home Bistro is a San Diego, California-based online home meal delivery company. Home Bistro provides high-quality, direct-to-consumer gourmet home meal replacement plans and health programs via its website at www.homebistro.com.

AlphaPoint Technology, Inc. (APPO), closed Wednesday's trading session at $0.15, up 20.00%, on 145,184 volume with 8 trades. The average volume for the last 60 days is 19,446 and the stock's 52-week low/high is $0.02/$0.20.

HealthTalk Live, Inc. (HLTK)

SmallCapVoice reported previously on HealthTalk Live, Inc. (HLTK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HealthTalk Live, Inc. is a consumer goods and media company headquartered in Santa Monica, California. The Company specializes in hemp-infused food and beverage products. Its Humbly Hemp is a product line of hemp based products. The snack line will feature hemp and CBD based foods. HealthTalk Live lists on the OTC Markets Group’s OTCQB.

Humbly Hemp bars are filled with plant-based protein, Omega 3’s, and sustainable and ethically-sourced ingredients. All of the Company’s natural products are produced and/or packaged for consumers in Humbly Hemp’s own dedicated facility. This facility is free of the most customary food allergens (peanuts, tree nuts, dairy, egg, soy, wheat, sesame, shellfish, fish, and mustard), gluten, preservatives, colors, artificial flavors, and genetically modified ingredients. 

In late June of this year, HealthTalk Live announced a joint venture (JV) with the Spring Hill Water Company of Cut Bank, Montana. The partnership agreement will permit Humble Water Company, a subsidiary of HealthTalk Live, to process and bottle water from this unique 3,000-year-old "protected" high pH aquifer.

Spring Hill Water Company, a Native American (Blackfeet Tribal Member) Corporation, and Humble Water Company agreed to build a facility, which will process and bottle water in 100 percent biodegradable bottles that generate annual revenues. Spring Hill Water's bio bottles speed up the natural biodegradation of plastics in biologically active landfills and anaerobic digesters as validated via independent certified laboratories employing globally recognized test methods. In addition, plastics enhanced with the bio bottles are Food and Drug Administration (FDA) recognized materials that are considered "food grade."

On July 11, 2017, HealthTalk Live announced that Humbly Hemp products will now be offered on Amazon.com. All Humbly Hemp bars begin with a base of gluten free rolled oats, hemp seeds, and plant protein. Humbly Hemp bars come in three flavors - Cinnamon Date, Berry Vanilla, and Cocoa + Sea Salt. During this fiscal year, Humbly Hemp’s plan is to introduce a number of new, innovative, hemp-infused products.

Mr. Daniel Crawford, HealthTalk Live Chief Executive Officer, said, "We conducted a survey to determine what was the best way to service our potential client base and the answer overwhelmingly was to offer products on Amazon.com.”

Yesterday, HealthTalk Live announced that Sunshine Specialties signed a brokerage deal to represent Humbly Hemp products. Sunshine has a broad area of established Natural Food Product retail clients in Southern California and Arizona. Sunshine Specialties’ emphasis is on quality manufacturers who have the potential for growth and also follow a marketing policy, which emphasizes creative and unique ideas. Sunshine Specialties has numerous well-known retail clients that they service. These include Whole Foods, Clark's Nutrition, and Natural Foods Markets and Sprouts Farmers Market, among others.

HealthTalk Live, Inc. (HLTK), closed Wednesday's trading session at $0.448, even for the day. The average volume for the last 60 days is 4,132 and the stock's 52-week low/high is $0.20/$0.89.

Endonovo Therapeutics, Inc. (ENDV)

Buzz Stocks, Damn Good Penny Picks, Penny Pick Finders, Innovative Marketing, SeeThruEquityResearch, HEROSTOCKS, Stock Brain, SmallCapVoice, PennyStockProphet, Planet Penny Stocks, SecretStockPromo, StockOnion, BestDamnPennyStocks, DSR News, Penny Picks, Penny Stock Newsletter, PHUB News, Stock Commander, TheNextBigTrade, PREPUMP STOCKS, and OTC Markets Group reported earlier on Endonovo Therapeutics, Inc. (ENDV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Endonovo Therapeutics, Inc. is a biotechnology company listed on the OTCQB. It is a foremost developer of bioelectronic-applications in cell therapies and non-invasive electroceuticals. The Company’s initial emphasis is on the treatment of acute and chronic inflammatory conditions of the liver utilizing its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease utilizing its ex vivo expanded and enhanced stem cells. Endonovo Therapeutics is concentrating its efforts on inflammatory conditions in vital organs. The Company is headquartered in Woodland Hills, California

Endonovo Therapeutics’ Immunotronics™ platform is a non-invasive, non-implantable, bioelectronic device for treating/preventing vital organ failure via the reduction of inflammation, cell death, and the promotion of regeneration. The Company’s Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

The purpose of its Cytotronics™ platform is to create optimized cell-based therapies with more therapeutic potential than the un-modulated cells now being used in regenerative medicine. The foundation for its Time-Varying Electromagnetic Field (TVEMF) technology was created at NASA in combination with the development of cell therapies to treat injuries and diseases, which astronauts might encounter during long term manned missions in space.

Endonovo Therapeutics is in the pre-clinical phase of evaluating its proprietary Immunotronic technology in the treatment of chronic and acute inflammatory conditions in the liver, including fulminant liver failure. It is developing a next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord.

The Company is expanding its liver disease research program and its Cytotronics™ platform to create a high-fidelity drug development and toxicology testing platform. Its Cytotronics™ platform employs bioelectronics to control and enhance cell functions. This permits 3D intelligent cell cultures to be implemented in growing and enhancing stem cells and tissues for the development of cell therapies, disease modeling, ADME (absorption, distribution, metabolism, and excretion) and toxicology testing.

Endonovo Therapeutics is starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in the treatment of critical limb ischemia (CLI). This pre-clinical study will evaluate the effect of Endonovo’s non-invasive electroceutical technology on limb function, ischemia damage, and blood flow. This includes the formation of new blood vessels (angiogenesis). The study is part of its strategy to develop a pipeline of non-invasive electroceutical treatments for vascular diseases, ischemia/reperfusion injuries, and ischemia wounds.

Endonovo is also starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in preventing and reversing inflammation in Non-Alcoholic Steatohepatitis (NASH). This study is the first of many currently planned studies targeting inflammatory pathologies of hepatic origin.

Furthermore, the Company is starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in preventing and reversing inflammation and fibrosis in kidney disease. This study is the first of numerous presently planned studies targeting inflammatory pathologies of renal origin. This includes ischemia/reperfusion injury, acute kidney injury, and diabetic nephropathy.

Endonovo Therapeutics, Inc. (ENDV), closed Wednesday's trading session at $0.0385, up 2.39%, on 2,710,359 volume with 99 trades. The average volume for the last 60 days is 1,810,913 and the stock's 52-week low/high is $0.0092/$0.22.

graphic

The QualityStocks
Company Corner

graphic
graphic

Lexaria Bioscience Corp. (LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.36, up 1.41%, on 62,559 volume with 50 trades. The stock’s average daily volume over the past 60 days is 77,581 and its 52-week low/high is $0.0913/$0.699.

CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the need for improved delivery technologies for cannabinoid-based therapies and four companies that are on the cutting edge with innovative systems. Lexaria Corp. (OTCQB: LXRP) has developed a lipid encapsulation technology which is discussed in regards to the primary issue with tablets and other swallowed medicine, namely, that they're subject to so-called first pass metabolism. Compounding this problem, studies have shown that cannabinoids do not tolerate acidic environments like the stomach.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Technology Discussed by CFN Media Cannabis Industry Coverage

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

National Research Council and Lexaria Bioscience Commence Laboratory Work

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.07328, up 9.00%, on 54,040 volume with 18 trades. The stock’s average daily volume over the past 60 days is 94,062, and its 52-week low/high is $0.0546/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Sully Project - E3 Target Drilling Underway

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0218, up 17.20%, on 15,363,946 volume with 549 trades. The stock’s average daily volume over the past 60 days is 8,506,347, and its 52-week low/high is $0.0075/$0.142.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication Discussing Public Companies Poised to Benefit from Rising Demand for Marijuana

SinglePoint Featured on MoneyTV with Donald Baillargeon, 7/14

NetworkNewsWire Announces Publication Discussing Emerging Standouts in the Legalized Marijuana Sector

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.9499, up 0.09%, on 94,473 volume with 73 trades. The stock’s average daily volume over the past 60 days is 50,662 and its 52-week low/high is $0.12/$2.75.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com Featured in New Interview with SmallCapVoice.com

ChineseInvestors.com, Inc.'s Subsidiary Files Record of its First Hemp-Infused Skin Care Line With China FDA

NetworkNewsWire Announces Publication Discussing a Variety of Cannabis Investment Options

Lexaria Bioscience Corp. (LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.36, up 1.41%, on 62,559 volume with 50 trades. The stock’s average daily volume over the past 60 days is 77,581 and its 52-week low/high is $0.0913/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

National Research Council and Lexaria Bioscience Commence Laboratory Work

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

ProTrader
(NAEI) +312.90%

2.

Pennystockmania
(DKGR) +42.86%

3.

Penny Picks
(NTCHF) +39.17%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251